Comparative Efficacy and Safety of Tapinarof 0.5% and 1% Cream Regimens for Atopic Dermatitis: A Network Meta-Analysis
Introduction: Atopic dermatitis (AD) is a chronic inflammatory skin disorder affecting quality of life. Tapinarof, a novel aryl hydrocarbon receptor (AhR) modulator, is a promising nonsteroidal treatmentbut, optimal dosing regimens remain unclear. Objectives: This network meta-analysis (NMA) comp...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Mattioli1885
2026-01-01
|
| Edice: | Dermatology Practical & Conceptual |
| Témata: | |
| On-line přístup: | https://www.dpcj.org/index.php/dpc/article/view/6042 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|